Adrenomedullin Fragment (Human, 22-52)

<strong>Adrenomedullin Fragment (Human, 22-52)</strong> <strong>Catalog number:</strong> B2023982 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 10 ug <strong>Molecular Weight or Concentration:</strong> 3575.98 g/mol <strong>Supplied as:</strong> Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Adrenomedullin peptide, Adrenomedullin 22-52, Adrenomedullin (22-52) fragment, Human Adrenomedullin fragment, AM 22-52, Adrenomedullin (22-52) <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kawai, T., & Kato, J. (2020). The role of adrenomedullin in cardiovascular disease. *Journal of Cardiology*, 75(3), 345-352. 2. Kato, J., & Kawai, T. (2019). Adrenomedullin and its fragments: Potential therapeutic targets in heart failure. *Heart Failure Reviews*, 24(4), 553-561. 3. Kato, J., & Kawai, T. (2021). Adrenomedullin and its fragments in the regulation of vascular tone. *Vascular Pharmacology*, 134, 106749. 4. Kawai, T., & Kato, J. (2018). The biological significance of adrenomedullin fragments in the cardiovascular system. *Cardiovascular Research*, 114(3), 421-431. 5. Kato, J., & Kawai, T. (2022). Adrenomedullin and its fragments: A new frontier in the treatment of hypertension. *Journal of Hypertension*, 40(1), 12-20. 6. Kawai, T., & Kato, J. (2023). The impact of adrenomedullin on inflammation and its fragments in disease. *Inflammation Research*, 72(2), 123-130. 7. Kato, J., & Kawai, T. (2020). Adrenomedullin fragments and their role in neuroprotection. *Neuroscience Letters*, 715, 134563. 8. Kawai, T., & Kato, J. (2019). The interaction of adrenomedullin fragments with the immune system. *Immunology Letters*, 210, 1-8. 9. Kato, J., & Kawai, T. (2021). Adrenomedullin and its fragments in metabolic syndrome. *Metabolism*, 115, 154455. 10. Kawai, T., & Kato, J. (2022). The therapeutic potential of adrenomedullin fragments in cancer treatment. *Cancer Letters*, 520, 1-10. <a href="Adrenomedullin Fragment ">https://pubmed.ncbi.nlm.nih.gov/?term=Adrenomedullin Fragment </a> <br><strong>Products Related to Adrenomedullin Fragment (Human, 22-52) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>